{"id":5613,"date":"2023-11-15T11:34:41","date_gmt":"2023-11-15T16:34:41","guid":{"rendered":"https:\/\/neoaptamers.com\/?p=5613"},"modified":"2026-04-13T14:24:46","modified_gmt":"2026-04-13T18:24:46","slug":"aptamers-a-novel-therapeutic-oligonucleotide","status":"publish","type":"post","link":"https:\/\/neoaptamers.com\/fr\/aptamers-a-novel-therapeutic-oligonucleotide\/","title":{"rendered":"Aptam\u00e8res : Un Nouvel Oligonucl\u00e9otide Th\u00e9rapeutique"},"content":{"rendered":"

Dans le domaine en constante \u00e9volution de la m\u00e9decine mol\u00e9culaire, les chercheurs sont constamment \u00e0 la recherche de th\u00e9rapies innovantes capables de cibler avec pr\u00e9cision et efficacit\u00e9 des mol\u00e9cules de maladies sp\u00e9cifiques. Les aptam\u00e8res, une classe d'oligonucl\u00e9otides synth\u00e9tiques, ont \u00e9merg\u00e9 comme un outil prometteur et polyvalent dans la qu\u00eate de th\u00e9rapies plus efficaces. Dans ce blog, nous explorerons le monde fascinant des aptam\u00e8res, leurs propri\u00e9t\u00e9s uniques et leur potentiel pour r\u00e9volutionner le traitement de diverses affections m\u00e9dicales.<\/p>\n

Qu'est-ce que sont les Aptam\u00e8res ?<\/h3>\n

Les aptam\u00e8res sont de courtes mol\u00e9cules d'ADN ou d'ARN \u00e0 brin simple qui peuvent se lier s\u00e9lectivement \u00e0 des mol\u00e9cules cibles sp\u00e9cifiques, telles que des prot\u00e9ines, des acides nucl\u00e9iques ou m\u00eame de petites mol\u00e9cules. Ces mol\u00e9cules sont souvent appel\u00e9es des \"anticorps chimiques\" en raison de leur capacit\u00e9 \u00e0 reconna\u00eetre et \u00e0 se lier \u00e0 leurs cibles avec une grande affinit\u00e9 et sp\u00e9cificit\u00e9.<\/p>\n

Le Processus de S\u00e9lection<\/h3>\n

Le processus de cr\u00e9ation des aptam\u00e8res implique une technique appel\u00e9e \"s\u00e9lection syst\u00e9matique des ligands par enrichissement exponentiel\" (SELEX). Pendant la SELEX, une biblioth\u00e8que al\u00e9atoire de s\u00e9quences d'ADN ou d'ARN est expos\u00e9e \u00e0 la mol\u00e9cule cible. Les s\u00e9quences qui se lient \u00e0 la cible sont isol\u00e9es et amplifi\u00e9es lors de plusieurs cycles de s\u00e9lection. Ce processus it\u00e9ratif permet d'identifier les aptam\u00e8res ayant la plus grande affinit\u00e9 de liaison pour la cible.<\/p>\n

Avantages des Aptam\u00e8res<\/h3>\n
    \n
  1. Haute sp\u00e9cificit\u00e9 : Les aptam\u00e8res pr\u00e9sentent une sp\u00e9cificit\u00e9 exceptionnelle pour leurs mol\u00e9cules cibles, r\u00e9duisant au minimum les effets hors cible.<\/li>\n
  2. Polyvalence : Ils peuvent \u00eatre con\u00e7us pour se lier \u00e0 une large gamme de cibles, y compris les prot\u00e9ines, les toxines et m\u00eame les cellules canc\u00e9reuses.<\/li>\n
  3. Stabilit\u00e9 : Les aptam\u00e8res sont stables et peuvent r\u00e9sister \u00e0 diff\u00e9rentes conditions environnementales, ce qui les rend adapt\u00e9s \u00e0 diverses applications.<\/li>\n
  4. Faible immunog\u00e9nicit\u00e9 : Contrairement \u00e0 certains autres agents th\u00e9rapeutiques, les aptam\u00e8res ont une faible immunog\u00e9nicit\u00e9, ce qui r\u00e9duit le risque de r\u00e9ponses immunitaires ind\u00e9sirables.<\/li>\n<\/ol>\n

    Applications des aptam\u00e8res<\/h3>\n
      \n
    1. Diagnostics: Les aptam\u00e8res sont utilis\u00e9s dans les tests de diagnostic pour d\u00e9tecter des biomarqueurs sp\u00e9cifiques associ\u00e9s \u00e0 des maladies, permettant ainsi un diagnostic pr\u00e9coce et une surveillance de la maladie.<\/li>\n
    2. Livraison de m\u00e9dicaments: Les aptam\u00e8res peuvent \u00eatre conjugu\u00e9s \u00e0 des m\u00e9dicaments, des nanoparticules ou des liposomes, facilitant la livraison cibl\u00e9e de m\u00e9dicaments aux sites de la maladie et r\u00e9duisant les effets secondaires.<\/li>\n
    3. Th\u00e9rapeutique: Les aptam\u00e8res ont montr\u00e9 leur efficacit\u00e9 en tant que th\u00e9rapeutiques pour diverses affections, notamment le cancer, les maladies auto-immunes et les infections virales. Ils peuvent bloquer l'activit\u00e9 des prot\u00e9ines li\u00e9es \u00e0 la maladie ou d\u00e9livrer des agents th\u00e9rapeutiques \u00e0 des cellules sp\u00e9cifiques.<\/li>\n
    4. Biosenseurs: Les aptam\u00e8res sont des composants essentiels des biosenseurs, permettant la surveillance en temps r\u00e9el d'\u00e9v\u00e9nements mol\u00e9culaires dans des \u00e9chantillons biologiques.<\/li>\n<\/ol>\n

      Exemples de th\u00e9rapies bas\u00e9es sur les aptam\u00e8res:<\/h3>\n
        \n
      1. Pegaptanib (Macugen) : Approuv\u00e9 par la FDA, le pegaptanib est une th\u00e9rapie bas\u00e9e sur les aptam\u00e8res utilis\u00e9e pour traiter la d\u00e9g\u00e9n\u00e9rescence maculaire li\u00e9e \u00e0 l'\u00e2ge en inhibant le facteur de croissance endoth\u00e9lial vasculaire (VEGF).<\/li>\n
      2. NOX-A12 : Cet aptam\u00e8re cible le r\u00e9cepteur de la chimiokine CXCL12 et est en cours d'\u00e9tude en tant que traitement potentiel du my\u00e9lome multiple et de la leuc\u00e9mie lympho\u00efde chronique.<\/li>\n
      3. AS1411 : AS1411 est un aptam\u00e8re qui se lie \u00e0 la nucl\u00e9oline, une prot\u00e9ine surexprim\u00e9e dans les cellules canc\u00e9reuses. Il est \u00e9tudi\u00e9 pour ses propri\u00e9t\u00e9s anticanc\u00e9reuses.<\/li>\n<\/ol>\n

        D\u00e9fis et Perspectives Futures<\/h3>\n

        Bien que les aptam\u00e8res pr\u00e9sentent de grandes promesses, plusieurs d\u00e9fis doivent \u00eatre relev\u00e9s. Cela comprend l'am\u00e9lioration de leur stabilit\u00e9, l'am\u00e9lioration de leur acheminement vers des tissus sp\u00e9cifiques et la r\u00e9duction des co\u00fbts de production. Les chercheurs travaillent activement \u00e0 surmonter ces obstacles et \u00e0 \u00e9tendre les applications cliniques des aptam\u00e8res.<\/p>\n

        Les aptam\u00e8res repr\u00e9sentent une nouvelle classe d'oligonucl\u00e9otides th\u00e9rapeutiques avec un potentiel immense pour r\u00e9volutionner le domaine de la m\u00e9decine. Leur haute sp\u00e9cificit\u00e9, leur polyvalence et leur stabilit\u00e9 en font des outils pr\u00e9cieux pour les diagnostics, la d\u00e9livrance de m\u00e9dicaments et les th\u00e9rapies cibl\u00e9es. \u00c0 mesure que la recherche dans ce domaine continue de progresser, nous pouvons envisager un avenir o\u00f9 les aptam\u00e8res joueront un r\u00f4le central dans le traitement d'une large gamme de maladies, am\u00e9liorant les r\u00e9sultats pour les patients et ouvrant la voie \u00e0 une m\u00e9decine plus personnalis\u00e9e et efficace.<\/p>","protected":false},"excerpt":{"rendered":"

        In the rapidly advancing field of molecular medicine, researchers are constantly on the lookout for innovative therapies that can target specific disease molecules with precision and efficacy. Aptamers, a class of synthetic oligonucleotides, have emerged as a promising and versatile tool in the quest for more effective therapeutics. In this blog, we will explore the… Lire la suite »Aptam\u00e8res : Un Nouvel Oligonucl\u00e9otide Th\u00e9rapeutique<\/span><\/a><\/p>","protected":false},"author":2,"featured_media":5615,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"neve_meta_sidebar":"","neve_meta_container":"","neve_meta_enable_content_width":"off","neve_meta_content_width":70,"neve_meta_title_alignment":"","neve_meta_author_avatar":"","neve_post_elements_order":"","neve_meta_disable_header":"","neve_meta_disable_footer":"","neve_meta_disable_title":"","footnotes":""},"categories":[8],"tags":[],"class_list":["post-5613","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-aptamers"],"yoast_head":"\nAptamers: A Novel Therapeutic Oligonucleotide<\/title>\n<meta name=\"description\" content=\"Explore the potential of aptamers as a novel therapeutic in medicine with high specificity and versatility for disease treatment.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/neoaptamers.com\/fr\/aptamers-a-novel-therapeutic-oligonucleotide\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Aptamers: A Novel Therapeutic Oligonucleotide\" \/>\n<meta property=\"og:description\" content=\"Explore the potential of aptamers as a novel therapeutic in medicine with high specificity and versatility for disease treatment.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/neoaptamers.com\/fr\/aptamers-a-novel-therapeutic-oligonucleotide\/\" \/>\n<meta property=\"og:site_name\" content=\"neoaptamers\" \/>\n<meta property=\"article:published_time\" content=\"2023-11-15T16:34:41+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-13T18:24:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/neoaptamers.com\/wp-content\/uploads\/2023\/11\/lbteam._a_bioscientist_in_a_lab_filled_with_light_studying_apta_3aac6d2e-4067-4208-8ce6-aed99945d942.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1456\" \/>\n\t<meta property=\"og:image:height\" content=\"816\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Gregory Penner\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Gregory Penner\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/aptamers-a-novel-therapeutic-oligonucleotide\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/aptamers-a-novel-therapeutic-oligonucleotide\\\/\"},\"author\":{\"name\":\"Gregory Penner\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#\\\/schema\\\/person\\\/641d6a3e016e13414b8d0d0ffd5847ad\"},\"headline\":\"Aptamers: A Novel Therapeutic Oligonucleotide\",\"datePublished\":\"2023-11-15T16:34:41+00:00\",\"dateModified\":\"2026-04-13T18:24:46+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/aptamers-a-novel-therapeutic-oligonucleotide\\\/\"},\"wordCount\":555,\"publisher\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/aptamers-a-novel-therapeutic-oligonucleotide\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/neoaptamers.com\\\/wp-content\\\/uploads\\\/2023\\\/11\\\/lbteam._a_bioscientist_in_a_lab_filled_with_light_studying_apta_3aac6d2e-4067-4208-8ce6-aed99945d942.png\",\"articleSection\":[\"Aptamers\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/aptamers-a-novel-therapeutic-oligonucleotide\\\/\",\"url\":\"https:\\\/\\\/neoaptamers.com\\\/aptamers-a-novel-therapeutic-oligonucleotide\\\/\",\"name\":\"Aptamers: A Novel Therapeutic Oligonucleotide\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/aptamers-a-novel-therapeutic-oligonucleotide\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/aptamers-a-novel-therapeutic-oligonucleotide\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/neoaptamers.com\\\/wp-content\\\/uploads\\\/2023\\\/11\\\/lbteam._a_bioscientist_in_a_lab_filled_with_light_studying_apta_3aac6d2e-4067-4208-8ce6-aed99945d942.png\",\"datePublished\":\"2023-11-15T16:34:41+00:00\",\"dateModified\":\"2026-04-13T18:24:46+00:00\",\"description\":\"Explore the potential of aptamers as a novel therapeutic in medicine with high specificity and versatility for disease treatment.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/aptamers-a-novel-therapeutic-oligonucleotide\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/neoaptamers.com\\\/aptamers-a-novel-therapeutic-oligonucleotide\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/aptamers-a-novel-therapeutic-oligonucleotide\\\/#primaryimage\",\"url\":\"https:\\\/\\\/neoaptamers.com\\\/wp-content\\\/uploads\\\/2023\\\/11\\\/lbteam._a_bioscientist_in_a_lab_filled_with_light_studying_apta_3aac6d2e-4067-4208-8ce6-aed99945d942.png\",\"contentUrl\":\"https:\\\/\\\/neoaptamers.com\\\/wp-content\\\/uploads\\\/2023\\\/11\\\/lbteam._a_bioscientist_in_a_lab_filled_with_light_studying_apta_3aac6d2e-4067-4208-8ce6-aed99945d942.png\",\"width\":1456,\"height\":816,\"caption\":\"bio scientist in a lab\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/aptamers-a-novel-therapeutic-oligonucleotide\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/neoaptamers.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Aptamers: A Novel Therapeutic Oligonucleotide\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#website\",\"url\":\"https:\\\/\\\/neoaptamers.com\\\/\",\"name\":\"Neoaptamers.com\",\"description\":\"Neoventures Biotechnology Inc.\",\"publisher\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/neoaptamers.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#organization\",\"name\":\"NeoVentures Biotechnology Inc.\",\"alternateName\":\"NVB\",\"url\":\"https:\\\/\\\/neoaptamers.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/neoaptamers.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/NeoVentures-Biotechnology-Square-Logo-No-Text-1.png\",\"contentUrl\":\"https:\\\/\\\/neoaptamers.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/NeoVentures-Biotechnology-Square-Logo-No-Text-1.png\",\"width\":500,\"height\":500,\"caption\":\"NeoVentures Biotechnology Inc.\"},\"image\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/neoventures-biotechnology-inc-\\\/\",\"https:\\\/\\\/www.reddit.com\\\/user\\\/NeoVenturesBiotech\\\/\",\"https:\\\/\\\/www.youtube.com\\\/@neoaptamers7964\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#\\\/schema\\\/person\\\/641d6a3e016e13414b8d0d0ffd5847ad\",\"name\":\"Gregory Penner\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/de665d788f86991000373f8dc389e0f6dcbb9228ffc3b4920b098d16c7c491e8?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/de665d788f86991000373f8dc389e0f6dcbb9228ffc3b4920b098d16c7c491e8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/de665d788f86991000373f8dc389e0f6dcbb9228ffc3b4920b098d16c7c491e8?s=96&d=mm&r=g\",\"caption\":\"Gregory Penner\"},\"description\":\"Dr. Gregory Penner academic training was a blend of very practical plant breeding theory combined with molecular biology. He has used this blend of biology and mathematics to first develop and lead a cereal biotechnology research team with the government of Canada and subsequently as a global research leader with Monsanto Inc. He has been a thought leader in aptamer development globally for the last twenty years as CEO and President of NeoVentures. \u00a0He has led this company to financial stability without outside investment with an integrated approach to aptamer discovery and commercialization. In 2015, he co- founded a second company, NeoNeuro in Paris France, focused on an innovative approach to identify Aptamarkers for complex diseases. Connect with Dr. Penner on LinkedIn or for company updates, follow NeoVentures. Click here to get in touch with our team.\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Aptam\u00e8res : Un Nouvel Oligonucl\u00e9otide Th\u00e9rapeutique","description":"Explore the potential of aptamers as a novel therapeutic in medicine with high specificity and versatility for disease treatment.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/neoaptamers.com\/fr\/aptamers-a-novel-therapeutic-oligonucleotide\/","og_locale":"fr_FR","og_type":"article","og_title":"Aptamers: A Novel Therapeutic Oligonucleotide","og_description":"Explore the potential of aptamers as a novel therapeutic in medicine with high specificity and versatility for disease treatment.","og_url":"https:\/\/neoaptamers.com\/fr\/aptamers-a-novel-therapeutic-oligonucleotide\/","og_site_name":"neoaptamers","article_published_time":"2023-11-15T16:34:41+00:00","article_modified_time":"2026-04-13T18:24:46+00:00","og_image":[{"width":1456,"height":816,"url":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2023\/11\/lbteam._a_bioscientist_in_a_lab_filled_with_light_studying_apta_3aac6d2e-4067-4208-8ce6-aed99945d942.png","type":"image\/png"}],"author":"Gregory Penner","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Gregory Penner","Dur\u00e9e de lecture estim\u00e9e":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/neoaptamers.com\/aptamers-a-novel-therapeutic-oligonucleotide\/#article","isPartOf":{"@id":"https:\/\/neoaptamers.com\/aptamers-a-novel-therapeutic-oligonucleotide\/"},"author":{"name":"Gregory Penner","@id":"https:\/\/neoaptamers.com\/#\/schema\/person\/641d6a3e016e13414b8d0d0ffd5847ad"},"headline":"Aptamers: A Novel Therapeutic Oligonucleotide","datePublished":"2023-11-15T16:34:41+00:00","dateModified":"2026-04-13T18:24:46+00:00","mainEntityOfPage":{"@id":"https:\/\/neoaptamers.com\/aptamers-a-novel-therapeutic-oligonucleotide\/"},"wordCount":555,"publisher":{"@id":"https:\/\/neoaptamers.com\/#organization"},"image":{"@id":"https:\/\/neoaptamers.com\/aptamers-a-novel-therapeutic-oligonucleotide\/#primaryimage"},"thumbnailUrl":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2023\/11\/lbteam._a_bioscientist_in_a_lab_filled_with_light_studying_apta_3aac6d2e-4067-4208-8ce6-aed99945d942.png","articleSection":["Aptamers"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/neoaptamers.com\/aptamers-a-novel-therapeutic-oligonucleotide\/","url":"https:\/\/neoaptamers.com\/aptamers-a-novel-therapeutic-oligonucleotide\/","name":"Aptam\u00e8res : Un Nouvel Oligonucl\u00e9otide Th\u00e9rapeutique","isPartOf":{"@id":"https:\/\/neoaptamers.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/neoaptamers.com\/aptamers-a-novel-therapeutic-oligonucleotide\/#primaryimage"},"image":{"@id":"https:\/\/neoaptamers.com\/aptamers-a-novel-therapeutic-oligonucleotide\/#primaryimage"},"thumbnailUrl":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2023\/11\/lbteam._a_bioscientist_in_a_lab_filled_with_light_studying_apta_3aac6d2e-4067-4208-8ce6-aed99945d942.png","datePublished":"2023-11-15T16:34:41+00:00","dateModified":"2026-04-13T18:24:46+00:00","description":"Explore the potential of aptamers as a novel therapeutic in medicine with high specificity and versatility for disease treatment.","breadcrumb":{"@id":"https:\/\/neoaptamers.com\/aptamers-a-novel-therapeutic-oligonucleotide\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/neoaptamers.com\/aptamers-a-novel-therapeutic-oligonucleotide\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/neoaptamers.com\/aptamers-a-novel-therapeutic-oligonucleotide\/#primaryimage","url":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2023\/11\/lbteam._a_bioscientist_in_a_lab_filled_with_light_studying_apta_3aac6d2e-4067-4208-8ce6-aed99945d942.png","contentUrl":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2023\/11\/lbteam._a_bioscientist_in_a_lab_filled_with_light_studying_apta_3aac6d2e-4067-4208-8ce6-aed99945d942.png","width":1456,"height":816,"caption":"bio scientist in a lab"},{"@type":"BreadcrumbList","@id":"https:\/\/neoaptamers.com\/aptamers-a-novel-therapeutic-oligonucleotide\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/neoaptamers.com\/"},{"@type":"ListItem","position":2,"name":"Aptamers: A Novel Therapeutic Oligonucleotide"}]},{"@type":"WebSite","@id":"https:\/\/neoaptamers.com\/#website","url":"https:\/\/neoaptamers.com\/","name":"Neoaptamers.com","description":"Neoventures Biotechnology Inc.","publisher":{"@id":"https:\/\/neoaptamers.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/neoaptamers.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/neoaptamers.com\/#organization","name":"NeoVentures Biotechnology Inc.","alternateName":"NVB","url":"https:\/\/neoaptamers.com\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/neoaptamers.com\/#\/schema\/logo\/image\/","url":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2024\/07\/NeoVentures-Biotechnology-Square-Logo-No-Text-1.png","contentUrl":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2024\/07\/NeoVentures-Biotechnology-Square-Logo-No-Text-1.png","width":500,"height":500,"caption":"NeoVentures Biotechnology Inc."},"image":{"@id":"https:\/\/neoaptamers.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/neoventures-biotechnology-inc-\/","https:\/\/www.reddit.com\/user\/NeoVenturesBiotech\/","https:\/\/www.youtube.com\/@neoaptamers7964"]},{"@type":"Person","@id":"https:\/\/neoaptamers.com\/#\/schema\/person\/641d6a3e016e13414b8d0d0ffd5847ad","name":"Gregory Penner","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/de665d788f86991000373f8dc389e0f6dcbb9228ffc3b4920b098d16c7c491e8?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/de665d788f86991000373f8dc389e0f6dcbb9228ffc3b4920b098d16c7c491e8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/de665d788f86991000373f8dc389e0f6dcbb9228ffc3b4920b098d16c7c491e8?s=96&d=mm&r=g","caption":"Gregory Penner"},"description":"Dr. Gregory Penner academic training was a blend of very practical plant breeding theory combined with molecular biology. He has used this blend of biology and mathematics to first develop and lead a cereal biotechnology research team with the government of Canada and subsequently as a global research leader with Monsanto Inc. He has been a thought leader in aptamer development globally for the last twenty years as CEO and President of NeoVentures. \u00a0He has led this company to financial stability without outside investment with an integrated approach to aptamer discovery and commercialization. In 2015, he co- founded a second company, NeoNeuro in Paris France, focused on an innovative approach to identify Aptamarkers for complex diseases. Connect with Dr. Penner on LinkedIn or for company updates, follow NeoVentures. Click here to get in touch with our team."}]}},"_links":{"self":[{"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/posts\/5613","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/comments?post=5613"}],"version-history":[{"count":1,"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/posts\/5613\/revisions"}],"predecessor-version":[{"id":5614,"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/posts\/5613\/revisions\/5614"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/media\/5615"}],"wp:attachment":[{"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/media?parent=5613"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/categories?post=5613"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/tags?post=5613"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}